Prospective evaluation of glucose metabolism in patients undergoing coronary artery bypass grafting

Krzysztof Greberski1, Przemysław Guzik, Henryk Wysocki

  • 1Oddział Kardiochirurgii, Szpital im. J. Strusia, ul. Szkolna 8/12, 61-833 Poznań. kgreberski@poczta.onet.pl

Kardiologia Polska
|December 14, 2006
PubMed

Insights

Over 70% of patients undergoing coronary artery bypass grafting (CABG) have undiagnosed glucose metabolism disturbances. Early screening for these conditions is crucial for better patient outcomes.

Area of Science:

  • Cardiology
  • Endocrinology
  • Metabolic Disorders

Background:

  • Glucose metabolism disturbances are linked to increased risk of ischemic heart disease (IHD).
  • Undiagnosed IHD complications often precede the identification of glucose metabolism issues.
  • Previous evaluations of glucose metabolism disorders in patients undergoing CABG are limited.

Purpose of the Study:

  • To assess the prevalence of glucose balance disturbances in patients with stable IHD undergoing elective coronary artery bypass grafting (CABG).

Main Methods:

  • Prospective analysis of glucose metabolism in 117 consecutive IHD patients (under 80 years) scheduled for elective CABG.
  • Included history assessment, physical examination, biochemical studies, echocardiography.
  • Oral glucose tolerance tests (OGTT) were performed on patients without a prior diabetes mellitus diagnosis.

Main Results:

  • Pre-existing glucose disturbances identified in 35% of patients (28.2% diabetes, 1.7% impaired glucose tolerance).
  • OGTT revealed new diagnoses in 41.1% of previously undiagnosed patients (3.4% abnormal fasting glucose, 27.4% impaired glucose tolerance, 10.3% diabetes).
  • Only 29.1% of patients had normal glucose balance.

Conclusions:

  • Over 70% of patients undergoing elective CABG exhibit undiagnosed carbohydrate metabolism disturbances.
  • Mandatory assessment of glucose regulation is recommended for all patients undergoing elective CABG surgery.
Abstract